The preferred surgical choice for intermediate-risk papillary thyroid cancer: total thyroidectomy or lobectomy? a systematic review and meta-analysis

Author:

Cao Mingyu1,Yu Tiexin1,Miao Xingyu1,Wu Zhijing1,Wang Wenlong123

Affiliation:

1. Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China

2. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China

3. Clinical Research Center for Breast Cancer Control and Prevention in Hunan Province, Changsha, China. 410008

Abstract

Background: The optimal surgical approach for intermediate-risk papillary thyroid carcinoma (IR-PTC) (according to ATA definition), whether total thyroidectomy (TT) or lobectomy (LT), has remained a contentious clinical grey area for several decades. This systematic review and meta-analysis aim to provide robust evidence and address this clinical dilemma comprehensively. Materials and Methods: A comprehensive literature search was conducted in Pubmed, Embase, Web of Science, and the Cochrane Library from 1st January 2009 to 29th December 2023 to evaluate the impact of different surgical options (TT or LT) on patients with IR-PTC. The primary outcomes included survival, recurrence rates, and postoperative complications. I2 and sensitivity analysis was used to explore the heterogeneity. Results: A total of 8 studies involving 2984 participants were included in this meta-analysis and systematic review. The results indicated that LT was a superior choice for mitigating complications compared to TT (RR, 0.32; 95%CI, 0.24-0.44, P<0.01), particularly for transient complications (RR, 0.24; 95%CI, 0.08-0.65, P<0.01), such as the transient parathyroid dysfunction (RR, 0.04; 95%CI, 0.01-0.15, P<0.01). However, TT did not increase the risk of recurrent laryngeal nerve palsy (RR, 0.78; 95%CI, 0.24-2.47, P=0.67), hemorrhage/seroma (RR, 0.77; 95%CI, 0.48-1.25, P=0.30) and permanent complications (RR, 0.18; 95%CI, 0.02-1.42, P=0.10). Besides, both LT and TT presented similar effect on survival outcomes (Overall Survival: RR, 1.00; 95%CI, 0.97-1.03, P=0.92, Disease-Specific Survival: RR, 0.99; 95%CI, 0.97-1.02, P=0.69, Recurrence-Free Survival: RR, 1.00; 95%CI, 0.96-1.05, P=0.86), recurrence (RR, 1.05; 95%CI, 0.76-1.46, P=0.76). Conclusion: The present meta-analysis revealed that TT did not yield improved outcomes in IR-PTC patients, but was associated with an increased incidence of temporary complications. In light of these findings, it may be advisable to consider LT as the optimal choice for IR-PTC patients.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3